36th International Symposium on ALS/MND

San Diego, USA

Friday 5 December – Sunday 7 December 2025

  • Home
  • About
    • About the event
    • Accreditation
    • Past Symposia
    • Future dates
    • Sign up for updates
  • Sponsors/Exhibitors
    • Sponsors
    • Exhibitors
  • Programme
    • Programme
    • Abstracts Online
    • Plenary Speakers
    • Satellite meetings
    • Welcome Networking Reception
  • For Presenters
    • For Presenters
    • For Oral Presenters
    • For Poster Presenters
    • Poster Prize
  • Information
    • Venue
    • Accommodation
    • About San Diego
    • First Announcement
    • FAQs
      • FAQs for in-person attendance
      • FAQs for virtual attendance
  • Get Involved
    • Symposium Stories
    • Share your participation in the Symposium
    • Symposium Blogs
    • Symposium App
  • Register
  • Menu
Home » Symposium 2021 » What next for edaravone?

What next for edaravone?

Posted on by Symposium Admin

This blog will be published on 29th November 2021

Symp Blog coming soon

Posted in Symposium 2021.

Post navigation

← Update on clinical trials – part 2
Join us at the 32nd… →
logo
© 2025 MND Association: Registered in England. Registered Charity no. 294354
  • Contact
  • Sitemap
  • Cookies Policy
  • Privacy Policy
  • Terms and Conditions
  • Sign up for updates

Follow us

  • facebook
  • twitter
  • youtube
  • instagram
© 2022 MND Association: Registered in England. Registered Charity no. 294354
A SiteOrigin Theme